Sialometrical and sialochemical analysis of patients with chronic graft-versus-host disease - A prolonged study

Cancer Investigation

Volumn 21, Issue 1, 2003, Pages 34-40

  Nagler, R M ^a   Nagler, A ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

CGVHD; PBSCT; Saliva; Salivary glands; Sialochemistry; Sialometry

Indexed keywords

ALBUMIN; EPIDERMAL GROWTH FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MAGNESIUM; PHOSPHATE; PROTEIN; SODIUM;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHEMICAL ANALYSIS; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SALIVA ANALYSIS; SALIVARY GLAND DISEASE; SALIVARY GLAND EXAMINATION; SIALOMETRY; XEROSTOMIA;

ADOLESCENT; ADULT; ALBUMINS; CATIONS; CHRONIC DISEASE; EPIDERMAL GROWTH FACTOR; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PILOCARPINE; RHEOLOGY; SALIVA; SALIVARY PROTEINS; SALIVATION; XEROSTOMIA;

EID: 0037217117     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120016401     Document Type: Article

References (33)

1. Slavin, S.; Nagler, A. New developments in bone marrow transplantation. Curr. Opin. Oncol. 1991, 3, 254-271.
2. Sullivan, K.M.; Shulman, H.M.; Storb, R.; Weiden, P.L.; Witherspoon, R.P.; McDonald, G.B.; et al. Chronic graft vs host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981, 57, 266-276.
3. Peszkowski, M.J.; Fujiwara, K.; Warfvinge, G.; Larsson, A. Experimental graft versus host disease in the [BN x LEW] F1 rat hybrid as a model for autoimmune disease: study of early adenitis in lachrymal and salivary glands. Autoimmunity 1996, 24, 101-111.
4. Nagler, R.M.; Laufer, D.; Nagler, A. Parotid gland dysfunction in an animal model of chronic graft-versushost disease. Arch. Otolaryngol. Head Neck Surg. 1996, 122, 1057-1060.
5. Nagler, R.; Laufer, D.; Nagler, A. Parotid gland dysfunction in a murine model of acute graft versus host disease. Head & Neck 1998, 201, 58-62.
6. Nagler, R.M.; Sherman, Y.; Nagler, A. Histopathologic study of the human submandibular gland in graft vs host disease [GVHD]. J. Clin. Pathol. 1999, 52, 1-3.
7. Nagler, R.; Marmary, Y.; Krausz, Y.; Chrisin, R.; Markitziu, A.; Nagler, A. Major salivary gland dysfunction in human acute and chronic graft-versushost disease [GVHD]. Bone Marrow Transplant. 1996, 17, 219-224.
8. Singhal, S.; Mehta, J.; Rattenbury, H.; Powles, R.; Treleaven, J. Oral pilocarpine hydrochloride for the treatment of refractory xerostomia associated with chronic graft-versus-host disease. Blood 1995, 85, 1147-1148.
9. Singhal, S.; Powles, R.; Treleaven, J.; Rattenbury, H.; Mehta, J. Pilocarpine hydrochloride for symptomatic relief of xerostomia due to Chron. graft-versus-host Dis. or total-body Irradiat. after bone marrow Transplant. for hematologic malignancies. Leuk. Lymphoma 1997, 24, 539-543.
10. Nagler, R.M.; Nagler, A. Pilocarpine hydrochloride relieves xerostomia in chronic graft vs host disease patients: a sialometrical study. Bone Marrow Transplant. 1999, 23, 1-5.
11. Mandel, I.D. The role of saliva in maintaining oral homeostasis. J. Am. Dent. Assoc. 1989, 119, 298-304.
12. Fox, P.C.; Van Der Van, P.; Sonies, B.C.; Weijjenbach, J.M.; Baum, B.J. Xerostomia: evaluation of a symptom with increasing significance. J. Am. Dent. Assoc. 1985, 110, 519-525.
13. Ben-Aryeh, H.; Jungerman, T.; Szargel, R.; et al. Salivary flow-rate and composition in schizophrenic patients on clozapine: subjective reports and laboratory data. Biol. Psychiatry 1996, 39, 946-949.
14. Ben-Aryeh, H.; Serouya, R.; Kantger, Y.; et al. Oral health and salivary composition in diabetic patients. J. Diabet. Complicat. 1993, 7, 57-62.
15. Baum, J.B.; Costa, P.T.; Izutsu, T.K. Sodium handling by aging human parotid glands is inconsistent with a two-stage secretion model. Am. J. Physiol. 1984, 246, R35.
16. Lowry, O.H.; Rosebrough, N.J.; Farr, A.L.; et al. J. Biol. Chem. 1951, 193, 265.
17. Nexo, E.; Jorgensen, E.; Hansen, M.R. Human epidermal growth factor on molecular forms present in urine and blood. Regul. Pept. 1992, 42, 75-84.
18. Mancini, G.; Carbonara, A.D.; Heremans, J.F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965, 2, 235-254.
19. Izutsu, K.T.; Sullivan, K.M.; Schubert, M.M.; et al. Disordered salivary immunoglobulin secretion and sodium transport in human disease graft-versus host disease. Transplantation 1983, 35, 441-446.
20. Izutsu, K.T.; Schubert, M.M.; Trulove, E.L.; Shulman, H.M.; Sale, G.E.; Morton, T.H.; Ensign, W.Y.; Mersai, T.; Sullivan, K.M.; Oberg, S.; Thomas, E.D. The predictive value of elevated labial saliva sodium concentration: its relation to labial gland pathology in bone marrow transplant recipients. Hum. Pathol. 1983, 14, 29-35.
21. Chisholm, D.M.; Mason, D.K. Labial salivary gland biopsy in Sjogren's disease. J. Clin. Pathol. 1968, 21, 656-660.
22. Mandel, I.D.; Baurmash, H. Sialochemistry in Sjogren's syndrome. Oral Surg. Oral Med. Oral Pathol. 1976, 41, 182-187.
23. Gresik, E.W. The granular convoluted tubule [GCT] cell of rodent submandibular glands. Microsc. Res. Tech. 1994, 27, 1-24.
24. Marti, U.; Burwen, S.J.; Jones, A.L. Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: an update. Hepatology 1989, 9, 126-138.
25. Fisher, D.A. Epidermal growth factor in the developing mammal. Mead Johnson Symp. Perinat. Dev. Med. 1988, 32, 33-40.
26. Deville de Periere, D.; Arancibia, S. Salivary hormones: a new aspect of oral physiology. J. Physiol. [Paris] 1988-89, 83, 273-280.
27. Farriol, M.; Schwartz, S. Epidermal growth factor: is its application in nutrition feasible? Nutr. Hosp. 1995, 10, 69-73.
28. Sabbadini, E.; Berczi, I. The submandibular gland: a key organ in the neuro-immuno-regulatory network? Neuroimmunomodulation 1995, 2, 184-202.
29. Valdez, I.H.; Fox, P.C. Interactions of the salivary and gastrointestinal systems. I. The role of saliva in digestion. Dig. Dis. 1991, 9, 125-132.
30. Skov Olsen, P. Role of epidermal growth factor in gastroduodenal mucosal protection. J. Clin. Gastroenterol. 1988, 10, 146-151.
31. Epstein, J.B.; Emerton, S.; Guglietta, A.; Le, N. Assessment of epidermal growth factor in oral secretions of patients receiving radiation therapy for cancer. Oral Oncol. 1997, 33, 359-363.
32. Yang, J.; Tyler, L.W.; Donoff, R.B.; Song, B.; Torio, A.J.; Gallagher, G.T.; Tsuji, T.; Elovic, A.; McBride, J.; Yung, C.M.; Galli, S.J.; Weller, P.F.; Wong, D.T. Salivary EGF regulates eosinophil-derived TGF-alpha expression in hamster oral wounds. Am. J. Physiol. 1996, 270, 191-220.
33. Wu-Wa ng, C.Y.; Patel, M.; Feng, J.; Milles, M.; Wang, S.L. Decreased levels of salivary prostaglandin E2 and epidermal growth factor in recurrent aphthous stomatitis. Arch. Oral Biol. 1995, 40, 1093-1098.